Preliminary clinical trials of butocin (NSC-172755) in patients with generalized carcinoma of the breast.
D002293:Adenocarcinoma, Scirrhous / Q000601:surgery; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D005260:Female; D005998:Glycine / Q000627:therapeutic use; D006801:Humans; D007457:Iodine Radioisotopes; D008408:Mastectomy; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010051:Ovarian Neoplasms / Q000188:drug therapy; D010865:Pilot Projects; D011687:Purines / Q000627:therapeutic use*; D013440:Sulfides / Q000627:therapeutic use; D013997:Time Factors; D014631:Valerates / Q000627:therapeutic use
D000970:Antineoplastic Agents; D007457:Iodine Radioisotopes; D011687:Purines; D013440:Sulfides; D014631:Valerates; D005998:Glycine